{"id":400932,"date":"2020-12-16T08:58:31","date_gmt":"2020-12-16T13:58:31","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=400932"},"modified":"2020-12-16T08:58:31","modified_gmt":"2020-12-16T13:58:31","slug":"allied-expands-investor-base-by-securing-eligible-business-corporation-status","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/allied-expands-investor-base-by-securing-eligible-business-corporation-status\/","title":{"rendered":"Allied Expands Investor Base By Securing Eligible Business Corporation Status"},"content":{"rendered":"
\n

KELOWNA, British Columbia, Dec. 16, 2020 (GLOBE NEWSWIRE) — Allied Corp<\/a>.<\/u> (“Allied”) (OTCQB: ALID<\/strong>) \u2013 an international medical cannabis company focused on creating and providing targeted cannabinoid health solutions to address today\u2019s medical issues is pleased to announce the approval of its wholly owned subsidiary SECFAC Exchange Corporation (dba Allied Corp Pharmaceuticals (\u201cAllied Pharma\u201d)) as an Eligible Business Corporation (EBC) in British Columbia (BC), Canada. This program allows BC investors who purchase shares in Allied Pharma to obtain an immediate 30% tax credit on their investment if they invest through a registered EBC. As an example, an investor making a $100,000 investment in Allied would receive a $30,000 tax credit, thereby providing an immediate return on their original investment. A BC accredited individual investor may invest an annual maximum of $400,000. The investment is RRSP and TFSA eligible. There is no investment limit to BC corporate investors but an EBC is limited to raising up to $10 million.<\/p>\n

\u201cWe believe the EBC program will play an important role in expanding our investor base. This program has the potential to attract targeted investors to the company and offers them with a significant opportunity to become a part of the Allied vision,\u201d said Calum Hughes, CEO and Founder of Allied Corp.<\/p>\n

A public acknowledgement is expressed to Antonio A. Arias, CEO of ALAMidas Capital Partners, for advising Allied regarding the approval of Allied Pharma. Allied expresses gratitude to the Administrator of the BC Small Business Venture Capital program for the quick turnaround. Job creation through Research and Development activities, manufacturing and processing activities in BC, combined with the potential export businesses are expected benefits to all stakeholders.<\/p>\n

\n About Allied Corp. – <\/strong>
\n
\n https:\/\/allied.health\/<\/strong>
\n <\/a>\n <\/p>\n

\n Allied Corp.<\/a>\u00a0is an international medical cannabis production company with a mission to address today\u2019s medical issues by researching, creating and producing targeted cannabinoid health solutions. Allied Corp. uses an evidence-informed scientific approach to make this mission possible, through cutting-edge pharmaceutical research and development, innovative plant-based production and unique development of therapeutic products.<\/p>\n

\n Investor Relations:<\/strong>
\n
ir@allied.health
1-877-255-4337<\/p>\n

\n About ALAMidas Capital Partners Inc. – <\/strong>
\n
\n http:\/\/alamidascpartners.com\/<\/strong>
\n <\/a>
\n
ALAMidas Capital Partners is an early revenue stage to mid-market investors, focused on commercializing the entire hemp plant from CBD, food, and to fiber ventures, operating as an Independent Sponsor, while collaborating with the investee management team by accelerating value creation, professionalizing its systems and processes, to become institutional grade ready.<\/p>\n

\n Forward-Looking Statements:<\/strong>\n <\/p>\n

This press release contains \u201cforward-looking information\u201d within the meaning of applicable securities laws in Canada or \u201cforward-looking statements\u201d made pursuant to the \u201csafe harbour\u201d provisions of the United States Private Securities Litigation Reform Act of 1995 (collectively, \u201cforward-looking information\u201d). Forward-looking information may relate to the Company\u2019s future outlook and anticipated events, plans or results, and may include information regarding the Company\u2019s objectives, goals, strategies, future revenue or performance and capital expenditures, and other information that is not historical information. Forward-looking information can often be identified by the use of terminology such as \u201cbelieve,\u201d \u201canticipate,\u201d \u201cplan,\u201d \u201cexpect,\u201d \u201cpending,\u201d \u201cin process,\u201d \u201cintend,\u201d \u201cestimate,\u201d \u201cproject,\u201d \u201cmay,\u201d \u201cwill,\u201d \u201cshould,\u201d \u201cwould,\u201d \u201ccould,\u201d \u201ccan,\u201d the negatives thereof, variations thereon and similar expressions. The forward-looking information contained in this press release is based on the Company\u2019s opinions, estimates and assumptions in light of management\u2019s experience and perception of historical trends, current conditions and expected future developments, as well as other factors that management currently believes are appropriate and reasonable in the circumstances. Forward looking statements in this press release include the following: that Allied is leveraging the conditions in its Colombia grow operation and future Kelowna location to support its Research and Development efforts; that Allied is making important strides forward to position itself as a leader in the medical cannabis space, that Allied intends to make a series of proposed trademark and other intellectual property protection filings, as part of the Company\u2019s Intellectual Property and Pharma Development (IP&PD) Strategy, statements respecting the joint development, manufacturing, and introduction of TACTICAL RELIEF\u2122 branded products, and the use of proceeds from the offering of convertible notes.<\/p>\n

There can be no assurance that the underlying opinions, estimates and assumptions will prove to be correct. Risk factors that could cause actual results to differ materially from forward-looking information in this release include: the Company\u2019s exposure to legal and regulatory risk; the effect of the legalization of adult-use cannabis in Canada and Colombia on the medical cannabis industry is unknown and may significantly and negatively affect the Company\u2019s medical cannabis business; that the medical benefits, viability, safety, efficacy, dosing and social acceptance of cannabis are not as currently expected; that adverse changes or developments affecting the Company\u2019s main or planned facilities may have an adverse effect on the Company; that the medical cannabis industry and market may not continue to exist or develop as anticipated or the Company may not be able to succeed in this market; risks related to completion of the greenhouse construction in Colombia, risks related to market competition; risks related to the proposed adult-use cannabis industry and market in Canada and Colombia including the Company\u2019s ability to enter into or compete in such markets; that the Company has a limited operating history and a history of net losses and that it may not achieve or maintain profitability in the future; risks related to the Company\u2019s current or proposed international operations; risks related to future third party strategic alliances or the expansion of currently existing relationships with third parties; that the Company may not be able to successfully identify and execute future acquisitions or dispositions or successfully manage the impacts of such transactions on its operations; risks inherent to the operation of an agricultural business; that the Company may be unable to attract, develop and retain key personnel; risks resulting from significant interruptions to the Company\u2019s access to certain key inputs such as raw materials, electricity, water and other utilities; that the Company may be unable to transport its cannabis products to patients in a safe and efficient manner; risks related to recalls of the Company\u2019s cannabis products or product liability or regulatory claims or actions involving the Company\u2019s cannabis products; risks related to the Company\u2019s reliance on pharmaceutical distributors; that the Company, or the cannabis industry more generally, may receive unfavourable publicity or become subject to negative consumer or investor perception; that certain events or developments in the cannabis industry more generally may impact the Company\u2019s reputation or its relationships with customers or suppliers; that the Company may not be able to obtain adequate insurance coverage in respect of the risks that it faces, that the premiums for such insurance may not continue to be commercially justifiable or that there may be coverage limitations and other exclusions which may result in such insurance not being sufficient; that the Company may become subject to liability arising from fraudulent or illegal activity by its employees, contractors, consultants and others; that the Company may experience breaches of security at its facilities or losses as a result of the theft of its products; risks related to the Company\u2019s information technology systems; that the Company may be unable to sustain its revenue growth and development; that the Company may be unable to expand its operations quickly enough to meet demand or manage its operations beyond their current scale; that the Company may be unable to secure adequate or reliable sources of necessary funding; risks related to, or associated with, the Company\u2019s exposure to reporting requirements; risks related to conflicts of interest; risks related to fluctuations in foreign currency exchange rates; risks related to the Company\u2019s potential exposure to greater-than-anticipated tax liabilities; risks related to the protection and enforcement of the Company\u2019s intellectual property rights, or the intellectual property that it licenses from others; that the Company may become subject to allegations that it or its licensors are in violation of the intellectual property rights of third parties; that the Company may not realize the full benefit of the clinical trials or studies that it participates in; that the Company may not realize the full benefit of its licenses if the licensed material has less market appeal than expected and the licenses may not be profitable; as well as any other risks that may be further described in and the risk factors discussed in the Company’s continuous disclosure including its Management’s Discussion and Analysis sections in its Quarterly Reports on Form 10-Q, Annual Reports on Form 10-K and Current Reports on Form 8-K filed under the Company’s profile at www.sec.gov.<\/p>\n

Although management has attempted to identify important risk factors that could cause actual results to differ materially from those contained in the forward-looking information in this presentation, there may be other risk factors not presently known to the Company or that the Company presently believes are not material that could also cause actual results or future events to differ materially from those expressed in such forward-looking information in this presentation. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information. Accordingly, readers and viewers should not place undue reliance on forward-looking information, which speaks only as of the date made. The forward-looking information contained in this release represents the Company\u2019s expectations as of the date of this release or the date indicated, regardless of the time of delivery of the presentation. The Company disclaims any intention, obligation or undertaking to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required under applicable securities laws.<\/p>\n<\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

KELOWNA, British Columbia, Dec. 16, 2020 (GLOBE NEWSWIRE) — Allied Corp. (“Allied”) (OTCQB: ALID) \u2013 an international medical cannabis company focused on creating and providing targeted cannabinoid health solutions to address today\u2019s medical issues is pleased to announce the approval of its wholly owned subsidiary SECFAC Exchange Corporation (dba Allied Corp Pharmaceuticals (\u201cAllied Pharma\u201d)) as an Eligible Business Corporation (EBC) in British Columbia (BC), Canada. This program allows BC investors who purchase shares in Allied Pharma to obtain an immediate 30% tax credit on their investment if they invest through a registered EBC. As an example, an investor making a $100,000 investment in Allied would receive a $30,000 tax credit, thereby providing an immediate return on their original investment. A … <\/p>\n

Continue reading “Allied Expands Investor Base By Securing Eligible Business Corporation Status”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-400932","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nAllied Expands Investor Base By Securing Eligible Business Corporation Status - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/allied-expands-investor-base-by-securing-eligible-business-corporation-status\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Allied Expands Investor Base By Securing Eligible Business Corporation Status - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"KELOWNA, British Columbia, Dec. 16, 2020 (GLOBE NEWSWIRE) — Allied Corp. (“Allied”) (OTCQB: ALID) \u2013 an international medical cannabis company focused on creating and providing targeted cannabinoid health solutions to address today\u2019s medical issues is pleased to announce the approval of its wholly owned subsidiary SECFAC Exchange Corporation (dba Allied Corp Pharmaceuticals (\u201cAllied Pharma\u201d)) as an Eligible Business Corporation (EBC) in British Columbia (BC), Canada. This program allows BC investors who purchase shares in Allied Pharma to obtain an immediate 30% tax credit on their investment if they invest through a registered EBC. As an example, an investor making a $100,000 investment in Allied would receive a $30,000 tax credit, thereby providing an immediate return on their original investment. A … Continue reading "Allied Expands Investor Base By Securing Eligible Business Corporation Status"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/allied-expands-investor-base-by-securing-eligible-business-corporation-status\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-16T13:58:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExMjkyOSMzODgzNTIzIzIxODk4MzA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/allied-expands-investor-base-by-securing-eligible-business-corporation-status\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/allied-expands-investor-base-by-securing-eligible-business-corporation-status\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Allied Expands Investor Base By Securing Eligible Business Corporation Status\",\"datePublished\":\"2020-12-16T13:58:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/allied-expands-investor-base-by-securing-eligible-business-corporation-status\\\/\"},\"wordCount\":1620,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/allied-expands-investor-base-by-securing-eligible-business-corporation-status\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExMjkyOSMzODgzNTIzIzIxODk4MzA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/allied-expands-investor-base-by-securing-eligible-business-corporation-status\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/allied-expands-investor-base-by-securing-eligible-business-corporation-status\\\/\",\"name\":\"Allied Expands Investor Base By Securing Eligible Business Corporation Status - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/allied-expands-investor-base-by-securing-eligible-business-corporation-status\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/allied-expands-investor-base-by-securing-eligible-business-corporation-status\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExMjkyOSMzODgzNTIzIzIxODk4MzA=\",\"datePublished\":\"2020-12-16T13:58:31+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/allied-expands-investor-base-by-securing-eligible-business-corporation-status\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/allied-expands-investor-base-by-securing-eligible-business-corporation-status\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/allied-expands-investor-base-by-securing-eligible-business-corporation-status\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExMjkyOSMzODgzNTIzIzIxODk4MzA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExMjkyOSMzODgzNTIzIzIxODk4MzA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/allied-expands-investor-base-by-securing-eligible-business-corporation-status\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Allied Expands Investor Base By Securing Eligible Business Corporation Status\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Allied Expands Investor Base By Securing Eligible Business Corporation Status - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/allied-expands-investor-base-by-securing-eligible-business-corporation-status\/","og_locale":"en_US","og_type":"article","og_title":"Allied Expands Investor Base By Securing Eligible Business Corporation Status - Market Newsdesk","og_description":"KELOWNA, British Columbia, Dec. 16, 2020 (GLOBE NEWSWIRE) — Allied Corp. (“Allied”) (OTCQB: ALID) \u2013 an international medical cannabis company focused on creating and providing targeted cannabinoid health solutions to address today\u2019s medical issues is pleased to announce the approval of its wholly owned subsidiary SECFAC Exchange Corporation (dba Allied Corp Pharmaceuticals (\u201cAllied Pharma\u201d)) as an Eligible Business Corporation (EBC) in British Columbia (BC), Canada. This program allows BC investors who purchase shares in Allied Pharma to obtain an immediate 30% tax credit on their investment if they invest through a registered EBC. As an example, an investor making a $100,000 investment in Allied would receive a $30,000 tax credit, thereby providing an immediate return on their original investment. A … Continue reading \"Allied Expands Investor Base By Securing Eligible Business Corporation Status\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/allied-expands-investor-base-by-securing-eligible-business-corporation-status\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-16T13:58:31+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExMjkyOSMzODgzNTIzIzIxODk4MzA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"8 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/allied-expands-investor-base-by-securing-eligible-business-corporation-status\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/allied-expands-investor-base-by-securing-eligible-business-corporation-status\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Allied Expands Investor Base By Securing Eligible Business Corporation Status","datePublished":"2020-12-16T13:58:31+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/allied-expands-investor-base-by-securing-eligible-business-corporation-status\/"},"wordCount":1620,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/allied-expands-investor-base-by-securing-eligible-business-corporation-status\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExMjkyOSMzODgzNTIzIzIxODk4MzA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/allied-expands-investor-base-by-securing-eligible-business-corporation-status\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/allied-expands-investor-base-by-securing-eligible-business-corporation-status\/","name":"Allied Expands Investor Base By Securing Eligible Business Corporation Status - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/allied-expands-investor-base-by-securing-eligible-business-corporation-status\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/allied-expands-investor-base-by-securing-eligible-business-corporation-status\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExMjkyOSMzODgzNTIzIzIxODk4MzA=","datePublished":"2020-12-16T13:58:31+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/allied-expands-investor-base-by-securing-eligible-business-corporation-status\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/allied-expands-investor-base-by-securing-eligible-business-corporation-status\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/allied-expands-investor-base-by-securing-eligible-business-corporation-status\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExMjkyOSMzODgzNTIzIzIxODk4MzA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExMjkyOSMzODgzNTIzIzIxODk4MzA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/allied-expands-investor-base-by-securing-eligible-business-corporation-status\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Allied Expands Investor Base By Securing Eligible Business Corporation Status"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/400932","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=400932"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/400932\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=400932"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=400932"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=400932"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}